C
Crescent Biopharma, Inc. (CBIO)
NCM – Real vaqt narxi. Valyuta: USD
18.56
+1.57 (9.24%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
18.56
-0.00 (-0.00%)
Bozordan keyin: Jun 26, 2026, 4:36 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
18.56
+1.57 (9.24%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
18.56
-0.00 (-0.00%)
Bozordan keyin: Jun 26, 2026, 4:36 PM EDT
This stock has a consensus price target of $27.60 based on the ratings of 6 analysts. The high is $35.00 and the low is $22.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 22 | $ 27.6 | $ 35 |
| O’zgarish | 29.49% | 62.45% | 106.00% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-06-01 | — | HC Wainwright & Co. | — | Downgrades | Buy → Neutral |
| 2026-03-02 | 18.53% | HC Wainwright & Co. | $25 → $22 | Maintains | Buy |
| 2026-01-21 | 88.58% | Guggenheim | $35 | Initiates Coverage On | Buy |
| 2025-08-27 | 34.7% | HC Wainwright & Co. | $25 → $25 | Reiterates | Buy |
| 2025-08-25 | 40.09% | Jefferies | $26 | Initiates Coverage On | Buy |